d1e30690_dic_NECT___Inclusion_completed__Cancer_type
[Title] Randomized phase II study of afatinib alone or in combination with vinorelbine versus investigator’s choice of treatment in patients with HER2-positive breast cancer with pro-gressive brain metastases after trastuzumab or lapatinib based therapy [Country] FI [Cancer type] 
Breast cancer
Nordic NECT - Inclusion completed
Cancer type